Host iron availability in the pathogenesis of enteropathogenic Yersinia

肠道病原性耶尔森菌发病机制中宿主铁的可用性

基本信息

项目摘要

DESCRIPTION (provided by applicant): People with iron overload disorders are more susceptible to serious infections with Yersinia and other bacterial pathogens, yet how and why the course of infection differs in these individuals remains unclear. Mutations that predispose humans to one such iron overload disorder, hereditary hemochromatosis, are very common. One hereditary hemochromatosis-associated mutation in the High Iron Fe gene (Hfe-C282Y) is found in 10% of people of Northern European descent. People with hereditary hemochromatosis accumulate iron in their livers and other tissues, which can lead to increased oxidative stress and organ damage if left untreated. However, hereditary hemochromatosis is also associated with low macrophage iron and immune system defects. Several excellent mouse models of hereditary hemochromatosis exist that recapitulate many symptoms of the human disease. However, these models have been underutilized in terms of characterizing susceptibility to infection. We have identified a gene in the foodborne pathogen Yersinia pseudotuberculosis that controls expression of the type III secretion system (T3SS), a specialized apparatus required by all pathogenic Yersinia to cause disease. This gene has significant homology to the E. coli transcription factor IscR, whose activity is controlled by iron availability and oxidative stress, both of which are abnormal in hereditary hemochromatosis. We hypothesize that IscR is important for proper control of T3SS expression and virulence of Y. pseudotuberculosis and the related pathogen Y. enterocolitica in healthy and iron overloaded hosts. In Aim 1, we will determine the susceptibility of two distinct hereditary hemochromatosis mouse models to infection with Y. pseudotuberculosis and Y. enterocolitica, correlating bacterial replication with tissue iron content and production of inflammatory mediators. In Aim 2, we will determine the Y. pseudotuberculosis protein and RNA genes controlled by changes in iron availability as well as genes controlled by IscR. In addition, the impact of IscR on Y. pseudotuberculosis virulence in healthy and iron overloaded hosts will be determined using the hereditary hemochromatosis mouse models. At the conclusion of this study, we will have established several parameters controlling Yersinia infection in iron overloaded hosts, determined the identity of important Yersinia genes controlled by changes in iron availability, completed initial characterization of th previously-unstudied Yersinia IscR gene, and developed important new tools for further investigating Yersinia pathogenesis and iron overload.
描述(由申请人提供):铁超负荷疾病的患者更容易受到耶尔森氏菌和其他细菌病原体的严重感染,但是这些人的感染过程如何以及为什么这些人尚不清楚。使人类易受这种铁超载障碍(遗传性血色素肿瘤病)的突变非常普遍。在北欧下降的10%的人中,发现了高铁Fe基因(HFE-C282Y)中与遗传性血色素症相关的突变。遗传性血色素肿瘤病的人会在肝脏和其他组织中积聚铁,如果未治疗,可能会导致氧化应激和器官损伤增加。然而,遗传性血色素沉着症也与低巨噬细胞和免疫系统缺陷有关。存在几种出色的遗传性血色素沉着症小鼠模型,这些模型概括了人类疾病的许多症状。但是,这些模型在表征感染的易感性方面未被充分利用。我们已经确定了pseudotuberculcolosis的食源性病原体中的基因,该基因控制了III型分泌系统(T3SS)的表达,这是所有致病性耶尔森氏菌所要求的一种专门的设备,以引起疾病。该基因与大肠杆菌转录因子ISCR具有重要的同源性,其活性受铁的可用性和氧化应激控制,这两者在遗传性血色素沉着症中均异常。我们假设ISCR对于健康和铁超载宿主中Y. pseudotuberculosis的T3SS表达和Y.肠结肠炎病原体Y. y.肠结肠炎的相关病原体的毒力至关重要。在AIM 1中,我们将确定两种不同的遗传性血色素瘤小鼠模型对Y. pseudotuberculcolisos和Y.肠结肠膜菌感染感染的敏感性,将细菌复制与组织铁含量和产生炎症介体相关联。在AIM 2中,我们将确定由铁的可用性变化以及由ISCR控制的基因控制的Y. y. pseudotubolculosis蛋白和RNA基因。另外,使用遗传性血色素沉着小鼠模型确定ISCR对健康和铁超载宿主中的假结核病毒力的影响。在这项研究的结论中,我们将建立几个控制铁超载宿主中耶尔森氏菌感染的参数,确定了由铁可用性变化控制的重要耶尔西尼亚基因的身份,完成了先前未研究的Yersinia ISCR基因的初始特征,并开发了重要的新工具,以进一步研究Yersinia ia ia andiaia yersinia yernia exprentolos。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victoria Auerbuch Stone其他文献

Victoria Auerbuch Stone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victoria Auerbuch Stone', 18)}}的其他基金

Development of validated probes for the bacterial type III secretion system
开发用于细菌 III 型分泌系统的经过验证的探针
  • 批准号:
    10405053
  • 财政年份:
    2019
  • 资助金额:
    $ 18.37万
  • 项目类别:
Host iron and Yersinia pathogenesis
宿主铁与耶尔森氏菌发病机制
  • 批准号:
    9175810
  • 财政年份:
    2016
  • 资助金额:
    $ 18.37万
  • 项目类别:
Host iron and Yersinia pathogenesis
宿主铁与耶尔森氏菌发病机制
  • 批准号:
    9913985
  • 财政年份:
    2016
  • 资助金额:
    $ 18.37万
  • 项目类别:
Host iron and Yersinia pathogenesis
宿主铁与耶尔森氏菌发病机制
  • 批准号:
    9465421
  • 财政年份:
    2016
  • 资助金额:
    $ 18.37万
  • 项目类别:
Innate immunity-based screen for bacterial type III secretion system inhibitors
基于先天免疫的细菌 III 型分泌系统抑制剂筛选
  • 批准号:
    9044408
  • 财政年份:
    2014
  • 资助金额:
    $ 18.37万
  • 项目类别:
Innate immunity-based screen for bacterial type III secretion system inhibitors
基于先天免疫的细菌 III 型分泌系统抑制剂筛选
  • 批准号:
    9044549
  • 财政年份:
    2014
  • 资助金额:
    $ 18.37万
  • 项目类别:
Innate immunity-based screen for bacterial type III secretion system inhibitors
基于先天免疫的细菌 III 型分泌系统抑制剂筛选
  • 批准号:
    8696691
  • 财政年份:
    2014
  • 资助金额:
    $ 18.37万
  • 项目类别:
Host iron availability in the pathogenesis of enteropathogenic Yersinia
肠道病原性耶尔森菌发病机制中宿主铁的可用性
  • 批准号:
    8284228
  • 财政年份:
    2012
  • 资助金额:
    $ 18.37万
  • 项目类别:

相似国自然基金

等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
  • 批准号:
    32370714
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
  • 批准号:
    32371910
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
  • 批准号:
    82300353
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
  • 批准号:
    32302535
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
  • 批准号:
    82302575
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
  • 批准号:
    10645610
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
Creating an advanced multi-ancestral resource and tools for short tandem repeat analysis in the AOURP researcher workbench
在 AOURP 研究人员工作台中创建先进的多祖先资源和工具,用于短串联重复分析
  • 批准号:
    10798717
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
Germline Genetic Modifiers of Radiation Response
辐射反应的种系遗传修饰剂
  • 批准号:
    10741022
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
The genetics of tumor suppression by p53
p53 抑制肿瘤的遗传学
  • 批准号:
    10636305
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
Deciphering unintended large gene modifications in gene editing for sickle cell disease
破译镰状细胞病基因编辑中意外的大基因修饰
  • 批准号:
    10720685
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了